In this paper, we outline major events with regards to the HPV vaccine controversy in Japan since May 2014, highlighting long-term implications of the rapid drop in vaccination coverage and recommending how to best move forward.
Related content
In June 2013 the Japanese Ministry of Health, Labor, and Welfare…
Overview Human Papillomavirus (HPV) is the fourth biggest cause of mortality amongst women in Brazil according to the Pan American Health Organisation (PAHO) but COVID-19…
Overview The global community of practice around HPV vaccination is not formalised to cut across multiple disciplines, and thought leaders from low-…
This paper explores how Japan’s response to HPV vaccine concerns has been perceived across the globe.
The aim of this qualitative study was to provide an in-depth exploration and comparison of French mothers and adolescent girls’ perceptions of the risks and benefits of HPV vaccination.
This research aims to develop and evaluate a suite of feasible interventions based on artificial intelligence technologies checking extensions, real-time dashboards, and chatbots – that improve the ability to debunk misinformation, boost self-efficacy in the vaccination decision-making process.